Importation
Texas State Senate Passes Dangerous Foreign Drug Importation Program
With the passage of HB 25 in the Texas State Senate and Governor Abbott’s impending signature, Texas is poised to become the seventh state in the U.S. to attempt to create a program to import medicine from Canada. This policy has failed in six other states, cost taxpayers millions of dollars, and drawn opposition from the Canadian government.
[...]PSM analysis of Texas legislation HB 25, foreign drug importation
H.B. 25 would require Texas’ Health and Human Services Commission to design a program for bulk importing prescription medicines under 21 USC 384 of the U.S. Food, Drug, and Cosmetics Act, more commonly known as a Section 804 State Importation Program (SIP). Below, we outline the many reasons this proposal is unsafe and unworkable.
[...]Watch PSM’s Briefing for the 118th Congress, Washington D.C., February 28, 2023
On Tuesday, February 28, 2023, the Partnership for Safe Medicines convened pharmacists, law enforcement, policy experts and family advocates to educate legislators about key issues in the fight against counterfeit medicines. Learn more and watch the briefing here.
[...]Colorado’s dilemma: Should we save our citizens $141 million dollars this year or just burn millions to make a political point?
When Colorado published its list of prospective drugs to import in 2020, the states own numbers showed they could have saved more than $43 million just by switching to U.S. generics. Now, that number is $141 million.
[...]Why has Florida paid 27 million dollars for an empty warehouse?
When Governor Ron DeSantis signed HB19 into law in June 2019, he said that Florida was leading “the way toward affordable prescription drugs,” but over the past three years not a single person has received even one pill imported from Canada, and the state has spent millions.
[...]The Hollow Promise of Drug Importation Proposals
Tom Kubic—an FBI veteran, former president and CEO of the Pharmaceutical Security Institute, and president of PSM’s governing board—has the experience to know that the risks of drug importation are “unacceptably high” and the potential rewards are “virtually nil.”
[...]Former Florida Congresswoman Calls Drug Importation a ‘False Promise’.
So, what does all of this have to do with importing drugs from a friendly nation like Canada? The simple, inarguable fact is that, once we open up our drug supply, we can no longer ensure the safety of the products in it.
[...]Director of Health and Science Policy at Citizens Against Government Waste Calls Drug Importation Dangerous
Instead of wasting time and money on dangerous and faulty importation proposals, Congress should encourage the FDA to speed up the drug approval process and reduce the cost of program and application fees for future drug development. In 2022, the application fee for a human drug application will cost $1.6 million for drugs that don’t require clinical data and $3.1 million for medicines that do need clinical data.
[...]Drug Importation Is Not The Solution Americans Need
While working to find a way to provide relief to patients at the pharmacy counter, American politicians again look to the idea of drug importation as a possible solution. Looking at all the evidence, the Partnership for Safe Medicines believes such plans will not only make no difference in reducing patient out-of-pocket costs, but will…
[...]COVID’s Impact On The Flow Of Counterfeits
What have we learned about counterfeit medicines during the pandemic? And what does it mean for proposals to import the drug supplies of other countries like Canada?
[...]